Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn’s Disease
暂无分享,去创建一个
N. Hyman | W. Koltun | M. Ferrante | K. Crowell | E. Loftus | A. Spinelli | B. Verstockt | A. D'hoore | P. Fleshner | A. Lightner | K. Mathis | L. Raffals | N. Lauwers | Radhika K. Smith | C. Tse | N. McKenna | G. Ovsepyan | Francesca DiCandido | Nicholas P. McKenna
[1] K. Umanskiy,et al. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab , 2017, The American Journal of Gastroenterology.
[2] E. Loftus,et al. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease , 2017, Journal of Crohn's & colitis.
[3] S. Targan,et al. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. , 2015, Annals of surgery.
[4] G. Nguyen,et al. The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. , 2014, Journal of Crohn's & colitis.
[5] D. Fan,et al. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis. , 2014, International journal of surgery.
[6] A. Ford,et al. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. , 2013, Journal of Crohn's & Colitis.
[7] T. Perl,et al. Financial impact of surgical site infections on hospitals: the hospital management perspective. , 2013, JAMA surgery.
[8] Kristin Stephens,et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. , 2013, The New England journal of medicine.
[9] J. Monson,et al. Tobacco Smoking and Postoperative Outcomes After Colorectal Surgery , 2013, Annals of surgery.
[10] J. Marshall,et al. Meta‐analysis: peri‐operative anti‐TNFα treatment and post‐operative complications in patients with inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.
[11] G. Greenberg,et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. , 2012, The New England journal of medicine.
[12] D. Flum,et al. Importance of Perioperative Glycemic Control in General Surgery: A Report From the Surgical Care and Outcomes Assessment Program , 2012, Annals of surgery.
[13] S. Schreiber. Certolizumab pegol for the treatment of Crohn’s disease , 2011, Therapeutic advances in gastroenterology.
[14] L. Peyrin-Biroulet,et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease , 2011, Gut.
[15] P. Rutgeerts,et al. A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. , 2008, Gastroenterology.
[16] S. Schreiber,et al. Certolizumab pegol for the treatment of Crohn's disease. , 2007, The New England journal of medicine.
[17] S. Schreiber,et al. Maintenance therapy with certolizumab pegol for Crohn's disease. , 2007, The New England journal of medicine.
[18] P. Rutgeerts,et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. , 2006, Gastroenterology.
[19] P. Rutgeerts,et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. , 2004, Gastroenterology.
[20] A. Zinsmeister,et al. Azathioprine or 6-Mercaptopurine Before Colectomy for Ulcerative Colitis Is Not Associated With Increased Postoperative Complications , 2002, Inflammatory bowel diseases.
[21] S. Hanauer,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[22] W E Wilkinson,et al. The Impact of Surgical-Site Infections in the 1990s: Attributable Mortality, Excess Length of Hospitalization, And Extra Costs , 1999, Infection Control & Hospital Epidemiology.
[23] P. Rutgeerts,et al. Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. , 2016, The New England journal of medicine.
[24] Sitthichai Vachirasrisirikul,et al. Incisional surgical site infection in colorectal surgery patients. , 2012, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[25] G. D'Haens,et al. Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab: A Randomized Trial , 2008 .
[26] P. Rutgeerts,et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. , 2007, Gastroenterology.